OCS
Oculis Holding AG
NASDAQ · Healthcare · Biotechnology · CH
$10.14
+1.60%Institutional positioning
13F filings over the trailing two quarters
New 44Increased 34Reduced 20Sold out 18
| Filer | Action | Shares | Filed |
|---|---|---|---|
| EQT Fund Management S.a r.l. | Increased | 6,950,294 | Aug 13, 2026 |
| EQT FUND MANAGEMENT S.A R.L. | Unchanged | 5,900,294 | May 14, 2026 |
| Gildi - lifeyrissjodur | Reduced | 2,430,401 | Apr 14, 2026 |
| Aberdeen Group plc | Increased | 2,159,809 | Jul 31, 2026 |
| MILLENNIUM MANAGEMENT LLC | Increased | 2,042,467 | Aug 14, 2026 |
| ABRDN PLC | Unchanged | 1,746,946 | Apr 29, 2026 |
| PIVOTAL BIOVENTURE PARTNERS INVESTMENT ADVISOR LLC | Reduced | 1,680,283 | May 14, 2026 |
| Pivotal bioVenture Partners Investment Advisor LLC | Reduced | 1,506,250 | Aug 13, 2026 |
| WELLINGTON MANAGEMENT GROUP LLP | Reduced | 1,345,728 | May 15, 2026 |
| CITADEL ADVISORS LLC | Increased | 1,031,604 | Sep 2, 2026 |
| MILLENNIUM MANAGEMENT LLC | Increased | 913,034 | May 15, 2026 |
| BRAIDWELL LP | New Position | 834,183 | Aug 14, 2026 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | New Position | 833,209 | May 15, 2026 |
| PERCEPTIVE ADVISORS LLC | Increased | 808,827 | Aug 14, 2026 |
| Saturn V Capital Management LP | Increased | 684,880 | Aug 14, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings